2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Metabolic Complications 10-Years after Kidney Transplant

E. Lorenz, F. Cosio, M. Stegall.
Metabolic Regulation of Neuropeptides Induces Weight Loss and is Linked to Prolongation of Allograft Survival

M. Quante,^1,2 T. Heinbokel,¹ K. Minami,¹ Y. Nian,¹ A. Elkhal,¹ S. Tullius.¹
Metabolic Therapy as a Platform for CTLA4Ig Costimulation Blockade in Preventing Allograft Rejection

C-.H. Cheng,^1,2 C-.F. Lee,^1,2 G. Furtmüller,³ B. Oh,³ C. Patel,¹ Y-.C. Lo,¹ M. Fryer,³ G. Brandacher,³ J. Powell.¹
Metformin Use after Kidney Transplantation: A Safe Option in Carefully Selected Patients

F. Koraishy,¹ L. Vest,¹ Z. Zhang,¹ M. Schnitzler,¹ V. Dharnidharka,² D. Axelrod,³ R. Ouseph,¹ A. Naik,⁴ N. Lam,⁵ H. Randall,¹ T. Alhamad,² D. Segev,³ D. Brennan,³ B. Kasiske,⁶ G. Hess,⁷ K. Lentine.
MICA/B Polymorphisms and the Relationship of the Matching Degree between MICA/B and HLA of Related Donor-Recipient Pairs in Allo-HSCT

Y. Sun, Y. Hao, J. Jin, L. Ding, F. Liang, N. Liu, J. Long, X. Zhao, Y. Xi.
Micafungin Prophylaxis in Liver Transplant Recipients at High Risk for Invasive Fungal Infections

A. Nolan, N. Harriott, K. Startsman.
Microbiology and Outcomes of Febrile Neutropenia Episodes after Kidney Transplant

G. Dube, S. Husain, H. Morris, D. Cohen, S. Mohan.
Mid-Term Outcome of Donor Specific Antibody Positive Deceased Donor Kidney Transplantation with Peri-Transplant Desensitization

K. Osickova,¹ P. Hruba,² J. Slatinska,¹ A. Slavcev,² J. Fronek,² E. Honsova,² O. Viklicky.¹
Midodrine Associated with Increased Mortality on Liver Transplant Waitlist

J. Kalil, M. Hertl, E. Schadde, J. Poirier, N. Alvey, E. Chan.
Minimal Invasive Surgery is Feasible and Safe in Patients with Liver and Kidney Transplant Patients

W. Yin.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z